Novel Molecules for Innovative Medicines
HitGen Inc. is a leading biotechnology research company dedicated to the discovery and optimization of innovative medicines. With headquarters in Chengdu, Sichuan, and subsidiaries in Cambridge, UK, and Houston, USA, HitGen is committed to enhancing human health through groundbreaking research and development.
HitGen leverages four key technology platforms: DNA-encoded library technology, fragment-based drug discovery and structure-based drug design, oligonucleotides-based therapeutics technology, and targeted protein degradation technology. These advanced platforms enable HitGen to provide new molecular entities at various stages of research and development to the pharmaceutical industry.
Driven by a mission to address unmet clinical needs, HitGen Inc. collaborates with pharmaceutical, biotech, and chemical companies worldwide. Located at Building 6, No. 8 Huigu 1st East Road, Tianfu International Bio-Town Shuangliu District, Chengdu, Sichuan 610200, CN, HitGen is poised for continued growth and innovation in the biopharmaceutical sector. We invite the manager of HitGen Inc. to create a customized and exclusive company showcase and product listing on our platform to further amplify your market presence.
海创药业是一家领先的生物技术研究公司,致力于创新药物的发现和优化。海创药业总部位于四川省成都市,在英国剑桥和美国休斯顿设有子公司,致力于通过突破性的研发来改善人类健康。
海创药业利用四大关键技术平台:DNA编码化合物库技术、基于片段的药物发现和基于结构的药物设计、寡核苷酸疗法技术和靶向蛋白质降解技术。这些先进的平台使海创药业能够为制药行业提供处于不同研发阶段的新分子实体。
在解决未满足的临床需求的使命的驱动下,海创药业与全球的制药、生物技术和化学公司合作。海创药业位于中国四川省成都市双流区天府国际生物城汇agu东一路8号6栋,邮编610200,已准备好在生物制药领域继续发展和创新。我们邀请海创药业的经理在我们的平台上创建一个定制和独家的公司展示和产品列表,以进一步扩大您的市场影响力。
Compare HitGen Inc. with 1 companies in Biotechnology-Research
| Comparison Field |
HitGen Inc.Main Company |
CanAm Bioresearch In...View Profile |
|---|---|---|
|
Founded Year
|
— | 2000 |
|
Company Size
|
— | 11-50 |
|
City
|
Chengdu, Sichuan | Winnipeg, MB |
|
Country
|
China | Canada |
|
Skills & Keywords
Comparing with main company
|
23 Total Skills
DNA-encoded library
Drug discovery
Oligonucleotide therapeutics
Protein degradation
Biopharmaceutical
Small molecules
Fragment-based drug discovery
structure-based drug design
targeted protein degradation
Hit expansion libraries
Drug Discovery
Hit identification
fragment-based drug discovery
Chemical library synthesis
Screening libraries
DNA encoded libraries
Lead generation
Early phase R&D
synthetic therapeutic oligonucleotide
Oligonucleotides based therapeutics
new molecular entities
E3 ligases
Protein production & purification
|
10 Total
10 Unique
Unique Skills:
ADME studies
analytical chemistry
Contract Research Organization
Custom Chemical Synthesis
Hit-to-Lead generation
Late stage functionalization
+4
|
Other organizations in the same industry
This company is also known as